Global Immuno-oncology Therapy Market 2018-2025 : Industry Research Report, Key Players, Analysis, Segmentation and Forecast

MarketInsights.biz added fresh and detailed market study report that focuses on “Global Immuno-oncology Therapy Market 2018” offers essential concept into global Immuno-oncology Therapy industry along with unique market insights, current top Manufactures in Immuno-oncology Therapy industry, growth, challenges, subjects wise investigation of each chapters and approaching industry trends, which will help the customers to aim Immuno-oncology Therapy market. In addition, the report help the clients to see specifications of products and driving the long-term income and productivity of global market.

This report studies the global market size of Immuno-oncology Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Immuno-oncology Therapy in these regions.
This research report categorizes the global Immuno-oncology Therapy market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer.
In 2017, the global Immuno-oncology Therapy market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Immuno-oncology Therapy market based on company, product type, application and key regions.

The various contributors involved in the value chain of Immuno-oncology Therapy include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Immuno-oncology Therapy include
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda 

Market Size Split by Type
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others
Market Size Split by Application
Hospitals
Ambulatory Surgical Center
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Immuno-oncology Therapy market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Immuno-oncology Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Immuno-oncology Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Immuno-oncology Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Immuno-oncology Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Immuno-oncology Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Immuno-oncology Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Immuno-oncology Therapy Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Immuno-oncology Therapy Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Immune Checkpoint Inhibitors
1.4.4 Immune System Modulators
1.4.5 Cancer Vaccines
1.4.6 Others
1.5 Market by Application
1.5.1 Global Immuno-oncology Therapy Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Center
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Immuno-oncology Therapy Market Size
2.1.1 Global Immuno-oncology Therapy Revenue 2016-2025
2.1.2 Global Immuno-oncology Therapy Sales 2016-2025
2.2 Immuno-oncology Therapy Growth Rate by Regions
2.2.1 Global Immuno-oncology Therapy Sales by Regions
2.2.2 Global Immuno-oncology Therapy Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Immuno-oncology Therapy Sales by Manufacturers
3.1.1 Immuno-oncology Therapy Sales by Manufacturers
3.1.2 Immuno-oncology Therapy Sales Market Share by Manufacturers
3.1.3 Global Immuno-oncology Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Immuno-oncology Therapy Revenue by Manufacturers
3.2.1 Immuno-oncology Therapy Revenue by Manufacturers (2016-2018)
3.2.2 Immuno-oncology Therapy Revenue Share by Manufacturers (2016-2018)
3.3 Immuno-oncology Therapy Price by Manufacturers
3.4 Immuno-oncology Therapy Manufacturing Base Distribution, Product Types
3.4.1 Immuno-oncology Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immuno-oncology Therapy Product Category
3.4.3 Date of International Manufacturers Enter into Immuno-oncology Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Immuno-oncology Therapy Sales by Type
4.2 Global Immuno-oncology Therapy Revenue by Type
4.3 Immuno-oncology Therapy Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Immuno-oncology Therapy Breakdown Data by Application

6 North America
6.1 North America Immuno-oncology Therapy by Countries
6.1.1 North America Immuno-oncology Therapy Sales by Countries
6.1.2 North America Immuno-oncology Therapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Immuno-oncology Therapy by Type
6.3 North America Immuno-oncology Therapy by Application
6.4 North America Immuno-oncology Therapy by Company

7 Europe
7.1 Europe Immuno-oncology Therapy by Countries
7.1.1 Europe Immuno-oncology Therapy Sales by Countries
7.1.2 Europe Immuno-oncology Therapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immuno-oncology Therapy by Type
7.3 Europe Immuno-oncology Therapy by Application
7.4 Europe Immuno-oncology Therapy by Company

8 Asia Pacific
8.1 Asia Pacific Immuno-oncology Therapy by Countries
8.1.1 Asia Pacific Immuno-oncology Therapy Sales by Countries
8.1.2 Asia Pacific Immuno-oncology Therapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Immuno-oncology Therapy by Type
8.3 Asia Pacific Immuno-oncology Therapy by Application
8.4 Asia Pacific Immuno-oncology Therapy by Company

9 Central & South America
9.1 Central & South America Immuno-oncology Therapy by Countries
9.1.1 Central & South America Immuno-oncology Therapy Sales by Countries
9.1.2 Central & South America Immuno-oncology Therapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Immuno-oncology Therapy by Type
9.3 Central & South America Immuno-oncology Therapy by Application
9.4 Central & South America Immuno-oncology Therapy by Company

10 Middle East and Africa
10.1 Middle East and Africa Immuno-oncology Therapy by Countries
10.1.1 Middle East and Africa Immuno-oncology Therapy Sales by Countries
10.1.2 Middle East and Africa Immuno-oncology Therapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Immuno-oncology Therapy by Type
10.3 Middle East and Africa Immuno-oncology Therapy by Application
10.4 Middle East and Africa Immuno-oncology Therapy by Company

11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.1.4 Immuno-oncology Therapy Product Description
11.1.5 Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.2.4 Immuno-oncology Therapy Product Description
11.2.5 Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.3.4 Immuno-oncology Therapy Product Description
11.3.5 Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.4.4 Immuno-oncology Therapy Product Description
11.4.5 Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.5.4 Immuno-oncology Therapy Product Description
11.5.5 Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.6.4 Immuno-oncology Therapy Product Description
11.6.5 Recent Development
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.7.4 Immuno-oncology Therapy Product Description
11.7.5 Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.8.4 Immuno-oncology Therapy Product Description
11.8.5 Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.9.4 Immuno-oncology Therapy Product Description
11.9.5 Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Immuno-oncology Therapy
11.10.4 Immuno-oncology Therapy Product Description
11.10.5 Recent Development
11.11 Sanofi
11.12 Spectrum Pharmaceuticals
11.13 Takeda 

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Immuno-oncology Therapy Raw Material
13.1.2 Immuno-oncology Therapy Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)




How can we help you?:

Prove You are Human (required): captcha





Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)




How can we help you?:

Prove You are Human (required): captcha